<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF BIOSHIELD TECHNOLOGIES, INC. FOR THE 3 MONTHS ENDED
SEPTEMBER 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                      $5,739,061
<SECURITIES>                                         0
<RECEIVABLES>                                  125,908
<ALLOWANCES>                                         0
<INVENTORY>                                    172,719
<CURRENT-ASSETS>                             6,040,188
<PP&E>                                         122,072
<DEPRECIATION>                                  22,322
<TOTAL-ASSETS>                               6,158,732
<CURRENT-LIABILITIES>                        1,303,599
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     6,644,057
<OTHER-SE>                                  (1,788,924)
<TOTAL-LIABILITY-AND-EQUITY>                 6,158,732
<SALES>                                         87,854
<TOTAL-REVENUES>                                87,854
<CGS>                                           33,736
<TOTAL-COSTS>                                  114,379
<OTHER-EXPENSES>                               297,784
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              16,335
<INCOME-PRETAX>                               (373,562)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (373,562)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (373,562)
<EPS-PRIMARY>                                    (0.08)<F1>
<EPS-DILUTED>                                        0
<FN>
<F1>Diluted loss per common share is not disclosed because the effect of the 
exchange or exercise of common stock equivalents would be antidilutive
</FN>